Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What information is available on company profile pages?

Company profile pages provide comprehensive information including financial statements, earnings data, analyst ratings, institutional ownership, insider trading, SEC filings, and detailed business analysis.

How do I analyze a company's financial health?

Use our financial metrics including P/E ratio, debt-to-equity, revenue growth, profit margins, and cash flow analysis to evaluate a company's financial strength and growth potential.

How do I analyze ABUS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ABUS investment potential.

What is ABUS stock price today?

The current ABUS stock price is $4.42 as of 08 Dec '25. Get real-time ABUS stock price, historical data, and price charts on Financhill.

Is ABUS a good investment?

Evaluate ABUS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

What does Arbutus Biopharma Corp. (ABUS) do?

Arbutus Biopharma Corp. (ABUS) is a publicly traded company. View detailed company information, business model, financial statements, and corporate data on our ABUS company profile page.

How to buy ABUS stock?

To buy ABUS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ABUS?

View detailed market capitalization data and company valuation metrics for ABUS on our comprehensive analysis page.

What is the P/E ratio of ABUS?

Use our fundamental analysis tools to view ABUS P/E ratio and compare valuation metrics with industry peers.

What are ABUS earnings?

View ABUS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Sell

41

ABUS Quote, Financials, Valuation and Earnings

Last price:

$4.43

Seasonality move :

19.24%

Day range:

$4.31 - $4.45

52-week range:

$2.71 - $5.10

Dividend yield:

0%

P/E ratio:

--

P/S ratio:

57.86x

P/B ratio:

10.98x

Volume:

730.5K

Avg. volume:

1.1M

1-year change:

21.76%

Market cap:

$850.1M

Revenue:

$6.2M

EPS (TTM):

-$0.22

Arbutus Biopharma Corp. SEC Filings

Company	Filed	Form Type	Description
ABUS Arbutus Biopharma Corp.	11/07/2023	10-Q	10-Q filing on 11/07/2023	View Form
ABUS Arbutus Biopharma Corp.	08/03/2023	10-Q	10-Q filing on 08/03/2023	View Form
ABUS Arbutus Biopharma Corp.	05/04/2023	10-Q	10-Q filing on 05/04/2023	View Form
ABUS Arbutus Biopharma Corp.	11/09/2022	10-Q	10-Q filing on 11/09/2022	View Form
ABUS Arbutus Biopharma Corp.	08/04/2022	10-Q	10-Q filing on 08/04/2022	View Form
ABUS Arbutus Biopharma Corp.	05/05/2022	10-Q	10-Q filing on 05/05/2022	View Form
ABUS Arbutus Biopharma Corp.	11/04/2021	10-Q	10-Q filing on 11/04/2021	View Form
ABUS Arbutus Biopharma Corp.	08/05/2021	10-Q	10-Q filing on 08/05/2021	View Form
ABUS Arbutus Biopharma Corp.	05/05/2021	10-Q	10-Q filing on 05/05/2021	View Form
ABUS Arbutus Biopharma Corp.	11/05/2020	10-Q	10-Q filing on 11/05/2020	View Form
ABUS Arbutus Biopharma Corp.	08/07/2020	10-Q	10-Q filing on 08/07/2020	View Form
ABUS Arbutus Biopharma Corp.	05/11/2020	10-Q	10-Q filing on 05/11/2020	View Form
ABUS Arbutus Biopharma Corp.	03/06/2020	10-K	10-K filing on 03/06/2020	View Form
ABUS Arbutus Biopharma Corp.	03/05/2020	10-K	10-K filing on 03/05/2020	View Form
ABUS Arbutus Biopharma Corp.	11/06/2019	10-Q	10-Q filing on 11/06/2019	View Form
ABUS Arbutus Biopharma Corp.	08/05/2019	10-Q	10-Q filing on 08/05/2019	View Form
ABUS Arbutus Biopharma Corp.	05/06/2019	10-Q	10-Q filing on 05/06/2019	View Form
ABUS Arbutus Biopharma Corp.	03/07/2019	10-K	10-K filing on 03/07/2019	View Form
ABUS Arbutus Biopharma Corp.	11/07/2018	10-Q	10-Q filing on 11/07/2018	View Form
ABUS Arbutus Biopharma Corp.	08/03/2018	10-Q	10-Q filing on 08/03/2018	View Form
ABUS Arbutus Biopharma Corp.	05/04/2018	10-Q	10-Q filing on 05/04/2018	View Form
ABUS Arbutus Biopharma Corp.	03/16/2018	10-K	10-K filing on 03/16/2018	View Form
ABUS Arbutus Biopharma Corp.	11/02/2017	10-Q	10-Q filing on 11/02/2017	View Form
ABUS Arbutus Biopharma Corp.	08/03/2017	10-Q	10-Q filing on 08/03/2017	View Form
ABUS Arbutus Biopharma Corp.	05/17/2017	10-K	10-K filing on 05/17/2017	View Form
ABUS Arbutus Biopharma Corp.	05/04/2017	10-Q	10-Q filing on 05/04/2017	View Form
ABUS Arbutus Biopharma Corp.	03/22/2017	10-K	10-K filing on 03/22/2017	View Form
ABUS Arbutus Biopharma Corp.	12/22/2016	10-Q	10-Q filing on 12/22/2016	View Form
ABUS Arbutus Biopharma Corp.	11/03/2016	10-Q	10-Q filing on 11/03/2016	View Form
ABUS Arbutus Biopharma Corp.	08/04/2016	10-Q	10-Q filing on 08/04/2016	View Form
ABUS Arbutus Biopharma Corp.	05/04/2016	10-Q	10-Q filing on 05/04/2016	View Form
ABUS Arbutus Biopharma Corp.	03/11/2016	10-K	10-K filing on 03/11/2016	View Form
ABUS Arbutus Biopharma Corp.	03/09/2016	10-K	10-K filing on 03/09/2016	View Form

Related Companies

Get ABUS Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

ABUS

Sector

P/E ratio

--

23.75x

PEG ratio

--

-0.01x

P/B ratio

10.98x

1.83x

Price / LTM sales

57.86x

1.60x

Growth Metrics

ABUS

Sector

Revenue growth

-60.49%

4.85%

Earnings growth

61.27%

11.11%

Revenue (5-year growth)

0.53%

6.45%

Earnings forecast

-$0.03

-$0.20

Profitability

ABUS

Sector

Profitability FY 2024

$4.8M

$3.6M

Return on invested capital

-44.8%

-30.98%

Return on assets

-35.82%

-27.62%

Return on equity

-47.63%

-36.69%

Earnings Date

Last Earnings Date

Nov

13

Next Earnings Date

Mar

26

Estimated Next Earnings Date

Feb

12

Balance Sheet

ABUS

Sector

Total cash

$93.7M

$27.2M

Short term investments

$86.3M

$25.7M

Total assets

$131.7M

$79.7M

Long term debt

$4.1M

Stock Ideas

Buy

52

Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy or Sell?

Buy

56

Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy or Sell?

Buy

81

Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy or Sell?

Alerts

Buy

56

SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy or Sell?

Buy

62

PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Buy or Sell?

Sell

13

PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Arbutus Biopharma Corp. SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get ABUS Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?

Will Robinhood Win AI Investing?

Is Amazon an AI Stock?

Stock Ideas

Is NVDA Stock a Buy?

Is AAPL Stock a Buy?

Is GOOG Stock a Buy?

Alerts

SMX alert for Dec 6

PRAX alert for Dec 6

PSN alert for Dec 6

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

Stocks by Sector

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS